Our results suggest that PT% activity, E-selectin, P-selectin, PAI-1, and NLR are significantly correlated with glycemic control and could be used as adjuvant prognostic markers for vascular complications in type 2 diabetic patients. This evidence concerns the gene SELP and type 2 diabetes mellitus.